Holen Sie sich die Stockscreener-App
11.50
7.33%
-0.91
Handel nachbörslich:
11.50
Finanzdaten der Avalo Therapeutics Inc-Aktie (AVTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
0.571 | 0.236 | 0.643 | 0.475 |
| Cost Of Revenue |
63.80%
-0.08
|
-0.221 | 0.247 | 0.708 | 0.551 |
| Costs And Expenses |
298.19%
32.77
|
8.229 | 3.986 | 7.793 | 9.267 |
| Operating Income/Loss |
327.88%
-32.77
|
-7.658 | -3.75 | -7.15 | -8.792 |
| Nonoperating Income/Loss |
16,955%
-88.52
|
-0.519 | -1.47 | -1.036 | -1.155 |
| Income/Loss From Continuing Operations Before Tax |
1,383%
-121.28
|
-8.177 | -5.22 | -8.186 | -9.947 |
| Income Tax Expense/Benefit, Deferred |
177.78%
0.007
|
-0.009 | 0.008 | 0.007 | 0.008 |
| Income Tax Expense/Benefit |
177.78%
0.007
|
-0.009 | 0.008 | 0.007 | 0.008 |
| Income/Loss From Continuing Operations After Tax |
1,385%
-121.29
|
-8.168 | -5.228 | -8.193 | -9.955 |
Net Income/Loss
|
1,385%
-121.29
|
-8.168 | -5.228 | -8.193 | -9.955 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
103.58%
0.8594
|
-24.00 | 46.76 | 13.97 | 11.72 |
| Basic Earnings Per Share |
24.73%
-141.00
|
-113.04 | -0.11 | -0.59 | -0.85 |
| Diluted Earnings Per Share |
24.73%
-141.00
|
-113.04 | -0.11 | -0.59 | -0.85 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):